Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07121946. IPD Sharing: NO. Countries: 1. Publications: 0.
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02750670. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00664144. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06242834. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00008021. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003338. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05422521. IPD Sharing: NO. Countries: 1. Publications: 0.
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06536049. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT06160362. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study
ClinicalTrials.gov study NCT02691351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00551239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT00057447. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01955499. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
ClinicalTrials.gov study NCT00003963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT01569204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
ClinicalTrials.gov study NCT06393738. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04281420. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00775957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06210243. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.